JP2019517586A5 - - Google Patents

Download PDF

Info

Publication number
JP2019517586A5
JP2019517586A5 JP2019516085A JP2019516085A JP2019517586A5 JP 2019517586 A5 JP2019517586 A5 JP 2019517586A5 JP 2019516085 A JP2019516085 A JP 2019516085A JP 2019516085 A JP2019516085 A JP 2019516085A JP 2019517586 A5 JP2019517586 A5 JP 2019517586A5
Authority
JP
Japan
Prior art keywords
substituted
release composition
sustained release
poly
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019516085A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019517586A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/035874 external-priority patent/WO2017210668A1/en
Publication of JP2019517586A publication Critical patent/JP2019517586A/ja
Publication of JP2019517586A5 publication Critical patent/JP2019517586A5/ja
Pending legal-status Critical Current

Links

JP2019516085A 2016-06-03 2017-06-05 カッパオピオイド受容体アゴニストの持続放出組成物 Pending JP2019517586A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662345583P 2016-06-03 2016-06-03
US62/345,583 2016-06-03
PCT/US2017/035874 WO2017210668A1 (en) 2016-06-03 2017-06-05 Sustained release compositions of kappa-opioid receptor agonist

Publications (2)

Publication Number Publication Date
JP2019517586A JP2019517586A (ja) 2019-06-24
JP2019517586A5 true JP2019517586A5 (https=) 2020-07-27

Family

ID=60478002

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019516085A Pending JP2019517586A (ja) 2016-06-03 2017-06-05 カッパオピオイド受容体アゴニストの持続放出組成物

Country Status (5)

Country Link
US (1) US20200316159A1 (https=)
EP (1) EP3463306A4 (https=)
JP (1) JP2019517586A (https=)
CN (1) CN109789094A (https=)
WO (1) WO2017210668A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11690806B2 (en) 2018-05-24 2023-07-04 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
KR20260007295A (ko) 2018-05-24 2026-01-13 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
US11689849B2 (en) 2018-05-24 2023-06-27 Nureva, Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
US12215173B2 (en) 2019-08-07 2025-02-04 HUMANWELL PHARMACEUTICAL US, Inc. Kappa opioid receptor peptide amide ligands
CA3171225A1 (en) * 2020-03-18 2021-09-23 Bryan R. Wilson Oligosaccharide formulations of kappa opioid receptor agonists
KR20230024419A (ko) 2020-06-25 2023-02-20 휴먼웰 파마슈티컬 유에스 의학적 장애 치료용 펩티드
MX2023012087A (es) * 2021-04-14 2024-02-27 Titan Pharmaceuticals Inc Implantes de agonistas de los receptores kappa-opioides para tratamiento del prurito.
BR112023022439A2 (pt) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular
CN114873741B (zh) * 2022-05-31 2023-03-14 南京大学 一种脱氮缓释碳源材料及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2487577C (en) * 2002-05-31 2014-11-18 Titan Pharmaceuticals, Inc. Implantable polymeric device for sustained release of buprenorphine
CA2653072A1 (en) * 2006-05-26 2007-12-06 Cara Therapeutics, Inc. Method for elevating prolactin in mammals
MX2009005000A (es) * 2006-11-10 2009-10-12 Cara Therapeutics Inc Amidas de peptidos sinteticos.
US7842662B2 (en) * 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
WO2008131508A1 (en) * 2007-05-01 2008-11-06 Fundação De Amparo À Pesquisa Do Estado De São Paulo - Fapesp Analgesic compounds
TWI501788B (zh) * 2010-09-02 2015-10-01 含陰離子聚合物之抗破碎劑型
EP2928562A4 (en) * 2012-12-06 2016-06-22 Stealth Peptides Int Inc PEPTIDE THERAPEUTIC PRODUCTS AND METHODS OF USE

Similar Documents

Publication Publication Date Title
JP2019517586A5 (https=)
JP2012525393A5 (https=)
RU2428985C2 (ru) Лекарственная форма, содержащая оксикодон и налоксон
JP2016539134A5 (https=)
US11058638B2 (en) Tyrosine derivatives and compositions comprising them
JP2018524298A5 (https=)
JP2016536286A5 (https=)
RU2014111069A (ru) Лекарственные формы ингибитора гистондиацетилазы в комбинации с бендамутином и их применение
JP2017518334A5 (https=)
JP2010077141A5 (https=)
RU2011138962A (ru) Производные 4-изопропилфенилглюцита в качестве ингибиторов sglt1
JP2014526503A5 (https=)
JP2005525369A5 (https=)
EP3030238B1 (en) Methods of treating pruritic conditions mediated through histamine h-4 receptors
RU2013141559A (ru) Способ ингибирования клеток опухоли гамартомы
JP2019511204A (ja) コパンリシブバイオマーカー
JP2006518731A5 (https=)
KR101307650B1 (ko) 구역에 대한 경피 방법 및 패치
JP2011518168A5 (https=)
JP2021105005A (ja) 癌治療
US20220031657A1 (en) Pharmaceutical combination comprising lsz102 and ribociclib
WO2020102303A1 (en) Use of disulfiram and other compounds to treat cancers with loss of chromosome 16q and/or low expression of metallothionein proteins
RU2006138035A (ru) Применение производного фенотиазина для профилактики и/или лечения потери слуха
US9877978B2 (en) Compositions comprising NDGA derivatives and sorafenib and their use in treatment of cancer
JP2010509294A5 (https=)